IMS Health (IMS) Getting Somewhat Favorable News Coverage, Study Finds
News headlines about IMS Health (NYSE:IMS) have trended somewhat positive on Tuesday, Accern reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. IMS Health earned a news impact score of 0.21 on Accern’s scale. Accern also gave headlines about the information technology services provider an impact score of 43.2902422360666 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Shares of IMS Health (NYSE IMS) traded up $0.99 during midday trading on Tuesday, hitting $31.34. The stock had a trading volume of 4,031,300 shares, compared to its average volume of 1,266,943. The company has a market capitalization of $10,330.00 and a price-to-earnings ratio of 74.62. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.12 and a current ratio of 1.12. IMS Health has a one year low of $22.36 and a one year high of $31.59.
TRADEMARK VIOLATION NOTICE: “IMS Health (IMS) Getting Somewhat Favorable News Coverage, Study Finds” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://theolympiareport.com/2017/12/26/ims-health-ims-getting-somewhat-favorable-news-coverage-study-finds.html.
About IMS Health
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with Analyst Ratings Network's FREE daily email newsletter.